Literature DB >> 8649581

Pitfalls in the diagnosis of autoantibodies associated with paraneoplastic neurologic disease.

P Sillevis-Smitt1, G Manley, J W Moll, J Dalmau, J B Posner.   

Abstract

We studied the sera of 15 patients with Sjögren's syndrome using the Western blot technique for the presence of anti-Ro and anti-Hu (type 1 antineuronal nuclear autoantibody [ANNA-1]). All sera reacted with Ro-52 protein. Two of the Sjögren sera reacted with 38-kd bands on Western blots of rat cerebellar homogenate, resembling anti-Hu immunoreactivity. However, when reacted with purified human Purkinje cells or purified recombinant HuD protein, none of the sera immunoreacted with the Hu antigens. We recommend the use of either a recombinant Hu protein or the combination of immunohistochemistry and Western blot of purified human neuronal preparations to identify paraneoplastic antibodies. This approach will prevent the unnecessary workup for suspected lung cancer.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8649581     DOI: 10.1212/wnl.46.6.1739

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  4 in total

1.  Spontaneous neurological improvement in anti-Hu associated encephalomyelitis.

Authors:  T Byrne; W P Mason; J B Posner; J Dalmau
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-03       Impact factor: 10.154

2.  Low level anti-Hu reactivity: A risk marker for small cell lung cancer?

Authors:  Jeffrey A Tsou; Meleeneh Kazarian; Ankur Patel; Janice S Galler; Ite A Laird-Offringa; Catherine L Carpenter; Stephanie J London
Journal:  Cancer Detect Prev       Date:  2008-12-12

3.  Paraneoplastic antineuronal antibodies in patients with systemic autoimmune diseases.

Authors:  B Benyahia; Z Amoura; A Rousseau; C Le Clanche; A Carpentier; J C Piette; J Y Delattre
Journal:  J Neurooncol       Date:  2003-05       Impact factor: 4.130

4.  Asymmetric cerebellar ataxia and limbic encephalitis as a presenting feature of primary Sjögren's syndrome.

Authors:  Kiren Collison; Jeremy Rees
Journal:  J Neurol       Date:  2007-09-12       Impact factor: 6.682

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.